Elocon Related Published Studies
Well-designed clinical trials related to Elocon (Mometasone Furoate Topical)
Intranasal Mometasone Furoate Alleviates the Ocular Symptoms Associated with Seasonal Allergic Rhinitis: Results of a Post Hoc Analysis. [2008.07.12]
Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial. [2008.04]
Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. [2008.04]
Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. [2008.03]
Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. [2008.03]
Phimotic ring topical corticoid cream (0.1% mometasone furoate) treatment in children. [2007.10]
Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. [2007.09]
The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study. [2007.06]
The Role of Mometasone Furoate Aqueous Nasal Spray in the Treatment of Adenoidal Hypertrophy in the Pediatric Age Group: Preliminary Results of a Prospective, Randomized Study. [2007.05.28]
Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. [2007.03]
Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma. [2006.11]
The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. [2006.06]
Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis. [2006.05]
Once-daily evening administration of mometasone furoate in asthma treatment initiation. [2006.04]
A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. [2006.02]
Decongestant effects of nasal xylometazoline and mometasone furoate in persistent allergic rhinitis. [2005.12]
Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. [2005.12]
Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. [2005.12]
Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis. [2005.12]
Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma. [2005.12]
Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis. [2005.09]
Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids. [2005.08]
Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects. [2005.07]
Comparative potency of formulations of mometasone furoate in terms of inhibition of 'PIRHR' in the forearm skin of normal human subjects measured with laser doppler velocimetry. [2005.05]
Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. [2005.03]
A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis. [2005]
Well-designed clinical trials possibly related to Elocon (Mometasone Furoate Topical)
Comparative adrenocortical suppression in dogs with otitis externa following topical otic administration of four different glucocorticoid-containing medications. [2008.06]
Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma. [2008.05]
Steroids for acute sinusitis. [2007.04.18]
Is the usage of intranasal glucocorticosteroids alone in allergic rhinitis sufficient? [2006.05]
The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. [2006.04]
[Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone] [2005.05]
Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis. [2005.05]
Hydrocortisone butyrate 0.1% cream in the treatment of chronic dermatitis. [2005.02]
Development of questionnaires to measure patient preferences for intranasal corticosteroids in patients with allergic rhinitis. [2005.02]
Other research related to Elocon (Mometasone Furoate Topical)
Inhaled mometasone furoate improves health-related quality of life in patients with persistent asthma. [2008.11]
Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. [2008.10]
Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler. [2008.10]
Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study. [2008.09.02]
Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler. [2008.07.18]
Suppressive effects of topical mometasone furoate and tacrolimus on skin prick testing in children. [2008.03]
Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. [2008.01.29]
Mometasone furoate dry-powder inhaler for the control of persistent asthma. [2007.11]
Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma. [2007.11]
Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate. [2007.11]
Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate. [2007.09]
Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate. [2007.09]
Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammation. [2007.09]
Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus. [2007.08]
Onset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an environmental exposure chamber. [2007.07]
Quantitative analysis of nasal vascularization in allergic patients treated with mometasone furoate. [2007.06]
Mometasone furoate nasal spray: a review of safety and systemic effects. [2007]
[Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis] [2007]
The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma. [2006.12]
Cross-reactions to desoximetasone and mometasone furoate in a patient with multiple topical corticosteroid allergies. [2006.09]
Suppressive effects of mometasone furoate on an antigen-specific IgE antibody response and production of IL-4 in mice. [2006]
Eletriptan: a review of its use in the acute treatment of migraine. [2006]
Effects of mometasone furoate on a rat allergic rhinitis model. [2005.11.07]
Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study. [2005.04]
Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate. [2005]
Other possibly related research studies
Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost. [2007.01]
Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment. [2006]
Effects of intranasal corticosteroid on nasal adenosine monophosphate challenge in persistent allergic rhinitis. [2006.11]
Allergic contact dermatitis to basic red 46 occurring in an HIV-positive patient. [2006.08]
Immunotherapy for patients with persistent allergic rhinitis unsatisfied with free chronic pharmacotherapy. [2006.05]
[Psoriasis and mud bath therapy: clinical-experimental study] [2005.07]
Serum levels of parathyroid hormone and parathyroid-related peptide in psoriasis. [2005]
Density of Demodex folliculorum in perioral dermatitis. [2005]
Lichen striatus in a pregnant woman. [2005.08]
Foreign body reaction involving a Mantoux test site. [2005.08]
Comparison of allergen immunotherapy and drug treatment in seasonal rhinoconjunctivitis: a 3-years study. [2005.02]
Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. [2005.04]
The effect of topical corticosteroid on basic fibroblast growth factor in nasal polyp tissue. [2005.05]
Topical glucocorticosteroids in rhinitis: clinical aspects. [2006.10]
Alternative therapies in antibiotic-resistant infection. [2006]
[Peripheral anticholinergic syndrome] [2007.03]
Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function. [2008.05.28]
Long-term follow-up of children undergoing topical intranasal steroid therapy for adenoidal hypertrophy. [2008.05.20]
Intracellular delivery of nanoparticles of an antiasthmatic drug. [2008]
Identification and management of undiagnosed and undertreated allergic rhinitis in adults and children. [2008.05]
Expression of chloride channel protein CLC-3 in patients with allergic rhinitis: effect of topical corticosteroid treatment. [2008.03]
Allergic contact dermatitis with a fertilizer containing hydrogen cyanamide (Dormex). [2008]
Narrowband UVB therapy as an effective treatment for Schamberg's disease. [2008.02]
Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis. [2008.03]
Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids. [2007.02]
The treatment of asthma in children: inhaled corticosteroids. [2007]
Long-term follow-up of children undergoing topical intranasal steroid therapy for adenoidal hypertrophy. [2008.08]
Intranasally administered corticosteroids and neuropsychiatric disturbances: a review of the international pharmacovigilance programme of the World Health Organization. [2008.07]
Vancomycin-induced DRESS syndrome in a female patient. [2008]
Allergen specific nasal challenge to latex in children with latex allergy: clinical and immunological evaluation. [2008.04]
Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function. [2008.10]
Nitric oxide evaluation in upper and lower respiratory tracts in nasal polyposis. [2008.07]
|
